- JP-listed companies
- Carna Biosciences, Inc.
- Balance sheet
Carna Biosciences, Inc.【JP:4572】Balance sheet
Market cap
¥5.9B
P/E ratio
-2.8x
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | - | 627 | 1,625 | 2,161 | 1,856 | 1,355 | 4,915 | 4,299 | 3,818 | 3,379 | 2,889 | 2,108 | 517 |
| Inventories | - | 94 | 91 | 87 | 83 | 75 | 63 | 66 | 73 | 84 | 94 | 108 | 106 |
| Total current assets | - | 908 | 1,996 | 2,493 | 2,134 | 1,672 | 5,275 | 4,708 | 5,318 | 4,104 | 4,191 | 2,738 | 1,176 |
| Property, plant and equipment, net | - | 53 | 37 | 35 | 20 | 19 | 30 | 53 | 52 | 100 | 105 | - | - |
| Marketable securities, non-current | - | 241 | 286 | - | - | - | - | - | - | - | - | - | - |
| Total non-current assets | - | 314 | 342 | 74 | 56 | 99 | 102 | 127 | 114 | 162 | 158 | 34 | 54 |
| Total assets | - | 1,221 | 2,338 | 2,566 | 2,190 | 1,770 | 5,377 | 4,835 | 5,433 | 4,266 | 4,350 | 2,772 | 1,230 |
| Long-term debt, current | - | 39 | 65 | 142 | 154 | 205 | 271 | 162 | 211 | 120 | 120 | 20 | 8 |
| Total current liabilities | - | 196 | 236 | 271 | 342 | 400 | 1,055 | 727 | 775 | 436 | 376 | 223 | 168 |
| Total non-current liabilities | - | 196 | 231 | 556 | 471 | 482 | 468 | 284 | 342 | 188 | 96 | 74 | 752 |
| Total liabilities | - | 391 | 467 | 827 | 812 | 883 | 1,523 | 1,011 | 1,117 | 625 | 472 | 297 | 920 |
| Retained earnings | - | -3,336 | -2,880 | -3,170 | -3,907 | -5,117 | -4,289 | -1,038 | -1,573 | -2,922 | -4,075 | -6,254 | -1,981 |
| Stockholders' equity | 1,598 | 830 | 1,871 | 1,739 | 1,378 | 887 | 3,854 | 3,824 | 4,316 | 3,642 | 3,878 | 2,475 | 309 |